Nxera Pharma Co (Nxera Pharma Co) FCF Yield % : -5.14 (As of May. 01, 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nxera Pharma Co's Trailing 12-Month Free Cash Flow is $-43.15 Mil, and Market Cap is $839.95 Mil. Therefore, Nxera Pharma Co's FCF Yield % for today is -5.14%.

The historical rank and industry rank for Nxera Pharma Co's FCF Yield % or its related term are showing as below:

SOLTF' s FCF Yield % Range Over the Past 10 Years
Min: -13.09 Med: 1.47 Max: 9.59
Current: -5.14

During the past 13 years, the highest FCF Yield % of Nxera Pharma Co was 9.59%. The lowest was -13.09%. And the median was 1.47%.

SOLTF's FCF Yield % is ranked better than
72.36% of 1552 companies
in the Biotechnology industry
Industry Median: -14.81 vs SOLTF: -5.14

Nxera Pharma Co's FCF Margin % for the quarter that ended in Dec. 2023 was -15.98%.

Nxera Pharma Co FCF Yield % Historical Data

The historical data trend for Nxera Pharma Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co FCF Yield % Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

1.87

3.46

4.35

7.68

-4.76

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															15.92	-2.77	-6.24	-5.69	-3.62

Competitive Comparison of Nxera Pharma Co's FCF Yield %

For the Biotechnology subindustry, Nxera Pharma Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's FCF Yield % falls into.

Nxera Pharma Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nxera Pharma Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-42.533	/	894.464
	=	-4.76%

Nxera Pharma Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-8.092	*	4	/	894.464
	=	-3.62%

Nxera Pharma Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Nxera Pharma Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.